UroGen Pharma Ltd. (URGN) Insider Trading

Over the last 3 months, URGN insiders made 0 open-market buys and 3 sales, a net sale of -$793K (SEC Form 4). Over the last 6 months, 105 institutions increased and 110 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$792.7K
Insider trades by month Buys Sells
Sep
Oct
Nov
Feb
May
Jun
Context3-month price +95.5%Institutions mixed (13F)
DateInsiderTypeSharesPrice
Jun 24, 2026Robinson James A. Jr.directorGrant10,000$34.99
Jun 24, 2026Belldegrun AriedirectorGrant20,000$34.99
Jun 24, 2026Robinson James A. Jr.directorGrant8,000
Jun 24, 2026Holden StuartdirectorGrant20,000$34.99
Jun 24, 2026Schoenberg Markofficer: Chief Medical OfficerSell10,000$35.01
Jun 24, 2026Wildman Daniel GeorgedirectorGrant10,000$34.99
Jun 24, 2026Wildman Daniel GeorgedirectorGrant8,000
Jun 24, 2026BUTITTA CYNTHIA MdirectorGrant10,000$34.99
Jun 24, 2026BUTITTA CYNTHIA MdirectorGrant8,000
Jun 24, 2026WEN LEANAdirectorGrant10,000$34.99
Jun 24, 2026WEN LEANAdirectorGrant8,000
Jun 9, 2026Schoenberg Markofficer: Chief Medical OfficerSell5,222$27.30
Jun 9, 2026Schoenberg Markofficer: Chief Medical OfficerOption10,000
May 27, 2026Robinson James A. Jr.directorOption2,000
May 11, 2026Schoenberg Markofficer: Chief Medical OfficerSell10,000$30.00
Feb 27, 2026Robinson James A. Jr.directorOption2,000
Feb 19, 2026Barrett Elizabeth A.officer: Chief Executive OfficerGrant153,195
Feb 11, 2026Smith Jason Drewofficer: General CounselSell1,608$19.69
Feb 11, 2026Smith Jason Drewofficer: General CounselGrant32,609
Feb 11, 2026Smith Jason Drewofficer: General CounselOption6,667
Feb 11, 2026Smith Jason Drewofficer: General CounselSell2,654$19.69
Feb 11, 2026Smith Jason Drewofficer: General CounselOption5,500
Feb 11, 2026Smith Jason Drewofficer: General CounselSell3,217$19.69
Feb 11, 2026Smith Jason Drewofficer: General CounselOption3,333
Feb 4, 2026Schoenberg Markofficer: Chief Medical OfficerSell3,686$19.69
Feb 4, 2026Schoenberg Markofficer: Chief Medical OfficerSell1,843$19.69
Feb 4, 2026Schoenberg Markofficer: Chief Medical OfficerSell1,844$19.69
Feb 3, 2026Schoenberg Markofficer: Chief Medical OfficerOption6,666
Feb 3, 2026Degnan Chrisofficer: Chief Financial OfficerGrant32,609
Feb 3, 2026Schoenberg Markofficer: Chief Medical OfficerGrant20,000

Source: URGN SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their URGN positions over the last 6 months (SEC Form 13F).

Increased
105
New positions
62
Reduced
110
Sold out
49
Largest moves
InstitutionActionSharesFiled
RTW INVESTMENTS, LPUnchanged4.5MFeb 17, 2026
RTW INVESTMENTS, LPUnchanged4.5MMay 15, 2026
PARADIGM BIOCAPITAL ADVISORS LPIncreased4.5MFeb 17, 2026
BLACKROCK, INC.Increased2.8MMay 13, 2026
TORONTO DOMINION BANKNew Position2.6MMay 15, 2026
BLACKROCK, INC.Increased2.6MFeb 12, 2026
MORGAN STANLEYIncreased2.6MFeb 13, 2026
MORGAN STANLEYReduced2.6MMay 15, 2026
KYNAM CAPITAL MANAGEMENT, LPNew Position2.2MMay 15, 2026
JEFFERIES FINANCIAL GROUP INC.Unchanged2.2MMay 8, 2026
JEFFERIES FINANCIAL GROUP INC.Unchanged2.2MFeb 9, 2026
SILVERARC CAPITAL MANAGEMENT, LLCIncreased1.7MFeb 12, 2026
PARADIGM BIOCAPITAL ADVISORS LPReduced1.7MMay 15, 2026
ACORN CAPITAL ADVISORS, LLCIncreased1.7MMay 15, 2026
SG AMERICAS SECURITIES, LLCIncreased1.7MApr 16, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.